Pharma-Bio Serv, Inc. (PBSV)
- Previous Close
0.0000 - Open
0.4303 - Bid 0.4303 x --
- Ask 0.5000 x --
- Day's Range
0.4303 - 0.4303 - 52 Week Range
0.3100 - 0.7400 - Volume
1,981 - Avg. Volume
3,401 - Market Cap (intraday)
9.86M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Jun 12, 2025 - Jun 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 28, 2025
- 1y Target Est
1.50
Pharma-Bio Serv, Inc. operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services, including regulatory compliance, validation, technology transfer, engineering, project management, and process support services. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
www.pbsvinc.com75
Full Time Employees
October 31
Fiscal Year Ends
Sector
Industry
Recent News: PBSV
View MorePerformance Overview: PBSV
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PBSV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PBSV
View MoreValuation Measures
Market Cap
9.87M
Enterprise Value
-2.41M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.03
Price/Book (mrq)
0.82
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.19%
Return on Assets (ttm)
-3.33%
Return on Equity (ttm)
-3.81%
Revenue (ttm)
9.6M
Net Income Avi to Common (ttm)
-498.36k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
12.43M
Total Debt/Equity (mrq)
1.28%
Levered Free Cash Flow (ttm)
-1.01M